Previous Article | Next Article 
Journal of Virology, May 2006, p. 4292-4303, Vol. 80, No. 9
0022-538X/06/$08.00+0 doi:10.1128/JVI.80.9.4292-4303.2006
Copyright © 2006, American Society for Microbiology. All Rights Reserved.
Targeting of p300/CREB Binding Protein Coactivators by Simian Virus 40 Is Mediated through p53
Darrell R. Borger and
James A. DeCaprio*
Dana-Farber Cancer Institute, Department of Medical Oncology, Harvard Medical School, Boston, Massachusetts
Received 19 October 2005/
Accepted 8 February 2006
The primary transforming functions of simian virus 40 large T antigen (SV40 LT) are conferred primarily through the binding and inactivation of p53 and the retinoblastoma family members. Normal p53 function requires an association with the CREB binding protein (CBP)/p300 coactivators, and a ternary complex containing SV40 LT, p53, and CBP/p300 has been identified previously. In this report, we have evaluated a secondary function of p53 bound to the SV40 LT complex in mediating the binding of human CBP/p300. We demonstrate that p53 associated with SV40 LT was posttranslationally modified in a manner consistent with the binding of CBP/p300. Furthermore, expression of SV40 LT induced the proportion of p53 phosphorylated on S15. An essential function for p53 in bridging the interaction between SV40 LT and CBP/p300 was identified through the reconstitution of the SV40 LT-CBP/p300 complex upon p53 reexpression in p53-null cells. In addition, the SV40 LT-CBP/p300 complex was disrupted through RNA interference-mediated depletion of endogenous p53. We also demonstrate that SV40 LT was acetylated in a p300- and p53-dependent manner, at least in part through the CH3 domain of p300. Therefore, the binding of p53 serves to modify SV40 LT by targeting CBP and p300 binding to direct the acetylation of SV40 LT.
* Corresponding author. Mailing address: Dana-Farber Cancer Institute, Mayer Building 457, 44 Binney Street, Boston, MA 02115. Phone: (617) 632-3825. Fax: (617) 632-4760. E-mail:
james_decaprio{at}dfci.harvard.edu.
Journal of Virology, May 2006, p. 4292-4303, Vol. 80, No. 9
0022-538X/06/$08.00+0 doi:10.1128/JVI.80.9.4292-4303.2006
Copyright © 2006, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Hermannstadter, A., Ziegler, C., Kuhl, M., Deppert, W., Tolstonog, G. V.
(2009). Wild-Type p53 Enhances Efficiency of Simian Virus 40 Large-T-Antigen-Induced Cellular Transformation. J. Virol.
83: 10106-10118
[Abstract]
[Full Text]
-
Ahuja, D., Rathi, A. V., Greer, A. E., Chen, X. S., Pipas, J. M.
(2009). A Structure-Guided Mutational Analysis of Simian Virus 40 Large T Antigen: Identification of Surface Residues Required for Viral Replication and Transformation. J. Virol.
83: 8781-8788
[Abstract]
[Full Text]
-
Gao, D., Inuzuka, H., Korenjak, M., Tseng, A., Wu, T., Wan, L., Kirschner, M., Dyson, N., Wei, W.
(2009). Cdh1 Regulates Cell Cycle through Modulating the Claspin/Chk1 and the Rb/E2F1 Pathways. Mol. Biol. Cell
20: 3305-3316
[Abstract]
[Full Text]
-
Joubel, A., Chalkley, R. J., Medzihradszky, K. F., Hondermarck, H., Burlingame, A. L.
(2009). Identification of New p53 Acetylation Sites in COS-1 Cells. Mol. Cell. Proteomics
8: 1167-1173
[Abstract]
[Full Text]
-
Kadeppagari, R.-K., Sankar, N., Thimmapaya, B.
(2009). Adenovirus Transforming Protein E1A Induces c-Myc in Quiescent Cells by a Novel Mechanism. J. Virol.
83: 4810-4822
[Abstract]
[Full Text]
-
Hein, J., Boichuk, S., Wu, J., Cheng, Y., Freire, R., Jat, P. S., Roberts, T. M., Gjoerup, O. V.
(2009). Simian Virus 40 Large T Antigen Disrupts Genome Integrity and Activates a DNA Damage Response via Bub1 Binding. J. Virol.
83: 117-127
[Abstract]
[Full Text]
-
Bocchetta, M., Eliasz, S., De Marco, M. A., Rudzinski, J., Zhang, L., Carbone, M.
(2008). The SV40 Large T Antigen-p53 Complexes Bind and Activate the Insulin-like Growth Factor-I Promoter Stimulating Cell Growth. Cancer Res.
68: 1022-1029
[Abstract]
[Full Text]
-
Liu, Y., Kern, J. T., Walker, J. R., Johnson, J. A., Schultz, P. G., Luesch, H.
(2007). A genomic screen for activators of the antioxidant response element. Proc. Natl. Acad. Sci. USA
104: 5205-5210
[Abstract]
[Full Text]
-
Shun, M.-C., Daigle, J. E., Vandegraaff, N., Engelman, A.
(2007). Wild-Type Levels of Human Immunodeficiency Virus Type 1 Infectivity in the Absence of Cellular Emerin Protein. J. Virol.
81: 166-172
[Abstract]
[Full Text]